Carrier-mediated or specialized transport of drugs across the blood-brain barrier

Advanced Drug Delivery Reviews

Volumn 36, Issue 2-3, 1999, Pages 277-290

  Tsuji, Akira ^a,b   Tamai, Ikumi ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Amine transport; Amino acid transport; Blood brain barrier; Carrier mediated transport; Efflux; Monocarboxylate transport; P glycoprotein

Indexed keywords

AMINO ACIDS; BLOOD; BRAIN; DRUG PRODUCTS; NEUROPHYSIOLOGY; PROTEINS;

BLOOD-BRAIN BARRIER; CARRIER-MEDIATED TRANSPORT; MONOCARBOXYLATES; P-GLYCOPROTEIN;

CONTROLLED DRUG DELIVERY;

AMINE; AZELASTINE; BACLOFEN; CARBOXYLIC ACID; CARNITINE; CETIRIZINE; CYCLOSPORIN A; DIAZEPAM; DIGOXIN; DOXORUBICIN; DRUG CARRIER; EBIRATIDE; GABAPENTIN; GLUTATHIONE; GLYCOPROTEIN P; HEXOSE; KETOTIFEN FUMARATE; LEVODOPA; MEPYRAMINE; METHYLAZOXYMETHANOL GLUCOSIDE; METHYLDOPA; MEVINOLIN; PENICILLIN G; PEPTIDE; PHENYTOIN; PRAVASTATIN; SIMVASTATIN; UNINDEXED DRUG; VALPROIC ACID; VINCRISTINE;

AMINE TRANSPORT; AMINO ACID TRANSPORT; BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TRANSPORT; ENDOCYTOSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033526179     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00084-2     Document Type: Review

References (65)

1. Levin V.A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23:1980;682-684.
2. Pardridge W.M. Transport of small molecules through the blood-brain barrier: biology and methodology. Adv. Drug Deliv. Rev. 15:1995;5-36.
3. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mo C.A.A.M., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P.J., Berns A.J.M., Borst P. Destruction of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
4. M. Naito, T. Tsuruo, Role of P-glycoprotein in the blood-brain barrier, in: S. Gupta, T. Tsuruo (Eds.), Multidrug Resistance in Cancer Cells, John Wiley and Sons, Ltd., Chichester, 1996, pp. 321-333.
5. Tsuji A., Tamai I. Blood-brain barrier function of P-glycoprotein. Adv. Drug Deliv. Rev. 25:1997;287-298.
6. Bergley D.J. The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system. J. Pharm. Pharmacol. 48:1996;136-146.
7. Pardridge W.M., Oldendorf W.H. Kinetics of blood-brain barrier transport of hexoses. Biochim. Biophys. Acta. 382:1975;377-392.
8. Polt B., Porreca F., Szabo L.Z.et al. Glycopeptide enkephalin analogues produce analgesia in mice: Evidence for penetration of the blood-brain barrier. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7114-7118.
9. Agus D.B., Gambhir S.S., Pardridge W.M., Spielholz C., Baselga J., Vera J.C., Golde D.W. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporter. J. Clin. Invest. 100:1997;2842-2848.
10. +-dependent and phlorizine-inhibitable transport of glucose and cycasin in brain endothelial cells. J. Neurochem. 70:1998;772-777.
11. del Pino M.M.S., Peterson D.R., Hawkins R.A. Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier. J. Biol. Chem. 270:1995;14913-14918.
12. Wang Y., Welty D.F. The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysispharmacokinetic approach. Pharm. Res. 13:1996;398-403.
13. Shulkin B.L., Betz A.L., Koeppe R.A., Agranoff B.W. Inhibition of neutral amino acid transport across the human blood-brain barrier by phenylalanine. J. Neurochem. 64:1995;1252-1257.
14. Komura J., Tamai I., Senmaru M., Terasaki T., Tsuji A. Sodium and chloride ion-dependent transport of β-alanine across the blood-brain barrier. J. Neurochem. 67:1996;330-335.
15. Komura J., Tamai I., Senmaru M., Terasaki T., Sai Y., Tsuji A. Blood-to-brain active transport of β-alanine across the blood-brain barrier. FEBS Lett. 400:1997;131-135.
16. --dependent transport of taurine at the blood-brain barrier. Biochem. Pharmacol. 50:1995;1783-1793.
17. Benrabh H., Lefauconnier J.M. Glutamate is transported across the rat blood-brain barrier by a sodium-independent system. Neurosci. Lett. 210:1996;9-12.
18. Thomas S.A., Segal M.B. Saturation kinetics, specificity and NBMPR sensitivity of thymidine entry into the central nervous system. Brain Res. 760:1997;59-67.
19. 3H]trazofurin into guinea pig brain by a saturable mechanism. Methods Find. Exp. Clin. Pharmacol. 17:1995;407-414.
20. Terasaki T., Takakuwa S., Moritani S., Tsuji A. Transport of monocarboxylatic acids at the blood-brain barrier: studies with monolayerss of primary cultured bovine brain capillary endothelial cells. J. Pharmacol. Exp. Ther. 258:1991;932-937.
21. Kang Y.S., Terasaki T., Tsuji A. Acidic drug transport in vivo through the blood-brain barrier. A role of the transport carrier for monocarboxylic acids. J. Pharmacobio-Dyn. 13:1990;158-163.
22. Tamai I., Tsuji A. Drug delivery through the blood-brain barrier. Adv. Drug Deliv. Rev. 19:1996;401-424.
23. Tsuji A., Saheki A., Tamai I., Terasaki T. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier. J. Pharmacol. Exp. Ther. 267:1993;1085-1090.
24. Saheki A., Terasaki T., Tamai I., Tsuji A. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm. Res. 11:1994;305-311.
25. Takanaga H., Tamai I., Inaba S., Sai Y., Higashida H., Yamamoto H., Tsuji A. cDNA cloning and functional characterization of rat intestinal monocarboxylate transporter. Biochem. Biophys. Res. Commun. 217:1995;370-377.
26. Gerhart D.Z., Enerson B.E., Zhdankina O.Y., Leino R.L., Drewes L.R. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am. J. Physiol. 273:1997;E207-E213.
27. Ennis S.R., Ren X.D., Betz A.L. Mechanisms of sodium transport at the blood-brain barrier studied with in situ perfusion of rat brain. J. Neurochem. 66:1996;756-763.
28. Adkison K.D., Shen D.D. Uptake of valproic acid into rat brain is mediated by medium-chain fatty acid transporter. J. Pharmacol. Exp. Ther. 276:1996;1189-1200.
29. Sekine T., Watanabe N., Hosoyamada M., Kanai Y., Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J. Biol. Chem. 272:1997;18526-18529.
30. Joo F. Endothelial cells of the brain and other organ systems: some similarities and differences. Prog. Neurobiol. 48:1996;255-273.
31. Kang Y.S., Terasaki T., Ohnishi T., Tsuji A. In vivo and in vitro evidence for a common carrier-mediated transport of choline and basic drugs through the blood-brain barrier. J. Pharmacobio-Dyn. 13:1990;353-360.
32. Yamazaki M., Terasaki T., Yoshioka K., Nagata O., Kato H., Ito Y., Tsuji A. Mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures. Pharm. Res. 11:1994;975-978.
33. 1-antagonists and lipophilic basic drugs. Pharm. Res. 1:1994;1516-1519.
34. Mroczkowska E., Galla H.J., Nalecz M.J., Nalecz K.A. Evidence for an asymmetrical uptake of L-carnitine in the blood-brain barrier in vitro. Biochem. Biophys. Res. Commun. 241:1997;127-131.
35. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., Tsuji A. Molecular and functional identification of sodium ion-dependent high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273:1998;20378-20382.
36. Banks W.A., Audus K., Davis T.P. Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs. Peptides. 13:1992;1289-1294.
37. Kannan R., Kuhlenkamp J.F., Jeandidier E.et al. Evidence for carrier-mediated transport of glutathione across the blood-brain barrier. J. Clin. Invest. 85:1990;2009-2013.
38. Kannan R., Yi J.R., Tang D., Li Y., Zlokovic B.V., Kaprowitz N. Evidence for the existence of a sodium-dependent glutatione (GSH) transporter: Expression of bovine brain capillary mRNA and size fractions in Xenopus laevis oocytes and dissociation from gamma-glutamyltransferase and facilitative GSH transporters. J. Biol. Chem. 271:1996;9754-9758.
39. Miyamoto Y., Shiraga T., Yamamoto H., Haga H., Taketani Y., Tamai I., Sai Y., Tsuji A., Takeda E. Sequence and tissue distribution of rat intestinal oligopeptide transporter. Biochim. Biophys. Acta. 1305:1996;34-38.
40. Fei Y.-J., Kanai Y., Nussberger S., Ganapathy V., Leibach F.H., Romero M.F., Singh S.K., Boron W.F., Hediger M.A. Expression cloning of a mammalian proton-coupled oligotransporter. Nature. 368:1994;563-566.
41. +/peptide cotransporter. J. Biol. Chem. 270:1995;6456-6463.
42. +/peptide cotransporter mediating absorption of β-lactam antibiotics in the intestine and kidney. J. Pharmacol. Exp. Ther. 275:1995;1631-1637.
43. +/peptide cotransporter family, from human kidney. Biochim. Biophys. Acta. 1235:1995;461-466.
44. Tsuji A., Tamai I. Carrier-mediated intestinal transport of drugs. Pharm. Res. 13:1996;963-977.
45. Yamashita T., Shimada S., Guo W., Sato E. Kohmura, T. Hayakawa, T. Takagi, M. Tohyama, M., Cloning and functional expression of a brain peptide/histidine transporter. J. Biol. Chem. 272:1997;10205-10211.
46. W.M. Pardridge, Blood-brain barrier peptide transport and peptide drug delivery to the brain, in: M.D. Taylor, G.L. Amidon (Eds.), Peptide-based Drug Design, American Chemical Society, Washington DC., 1995, pp. 265-296.
47. T. Terasaki, A. Tsuji, Oligopeptide drug delivery to the brain importance of absorptive-mediated endocytosis and P-glycoprotein associated active efflux transport at the blood-brain barrier, in: M.D. Taylor, G.L. Amidon (Ed.), Peptide-based Drug Design, American Chemical Society, Washington DC., 1995, pp. 297-316.
48. Terasaki T., Takakuwa S., Saheki A., Moritani S., Shimura T., Tabata S., Tsuji A. Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: Studies with monolayers of primary cultured bovine brain capillary endothelial cells. Pharm. Res. 9:1992;529-534.
49. Shimura T., Tabata S., Terasaki T., Deguchi Y., Tsuji A. In vivo blood-brain barrier transport of a novel adrenocorticotropic hormone analogue, ebiratide, demonstrated by brain microdialysis and capillary depletion methods. J. Pharm. Pharmacol. 44:1992;583-588.
50. Terasaki T., Hirai K., Sato H., Kang Y.S., Tsuji A. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078, into the blood-brain barrier. J. Pharmacol. Exp. Ther. 251:1989;351-357.
51. Kumagai A.K., Eisenberg J.B., Pardridge W.M. Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. J. Biol. Chem. 262:1987;15214-15219.
52. Pardridge W.M., Triguero D., Buciak J.B. Transport of histone through the blood-brain barrier. J. Pharmacol. Exp. Ther. 251:1989;521-526.
53. Pardridge W.M., Boado R.J. Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein. FEBS Lett. 288:1991;30-32.
54. Tamai I., Sai Y., Kobayashi H., Kamata M., Wakamiya T., Tsuji A. Structure-internalization relationship for adsorptive-mediated endocytosis of basic peptides at the blood-brain barrier. J. Pharmacol. Exp. Ther. 280:1997;410-415.
55. Deguchi Y., Nozawa K., Yamada S., Yokoyama Y., Kimura R. Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system. J. Pharmacol. Exp. Ther. 280:1997;551-560.
56. Noe B., Hagenbuch B., Stieger B., Meier P.J. Isolation of multispecific organic anion and cardiac glycoside transporter from rat brain. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10346-10350.
57. Mayer U., Wageneaar E., Beijnen J.H., Smit J.W., Meijer D.K.F., van Asperen J., Borst P., Schinkel A.H. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein. Br. J. Pharmacol. 119:1996;1038-1044.
58. Kelly R.A., Smith T.W. Recognition and management of digitalis toxicity. Am. J. Cardiol. 69:1992;108G-119G.
59. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A.A.M., Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96:1995;1698-1705.
60. Tishler D.M., Weinberg K.I., Hinton D.R., Barbaro N., Annett G.M., Raffel C. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia. 36:1995;1-6.
61. Naora K., Shen D.D. Mechanism of valproic acid uptake by isolated rat brain microvessels. Epilepsy Res. 22:1995;97-106.
62. Adkison K.D., Powers K.M., Artru A.A., Shen D.D. Effect of para-aminohippurate on the efflux of valproic acid from the central nervous system of the rabbit. Epilepsy Res. 23:1996;95-104.
63. Ooie T., Suzuki H., Terasaki T., Sugiyama Y. Cooperative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs. J. Pharmacol. Exp. Ther. 278:1996;590-596.
64. Ooie T., Terasaki T., Suzuki H., Sugiyama Y. Quantitative brain microdialysis study on the mechanism of quinolone distribution in the central nervous system. Drug Metab. Dispos. 25:1997;784-789.
65. Griffiths N.M., Hirst B.H., Simmons N.C. Active intestinal secretion of the fluoroquinolone antibacterial ciplofloxacin, norfloxacin and pefloxacin, a common secretory pathway? J. Pharmacol. Exp. Ther. 269:1994;496-502.